Atlas Trials

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

Clinical trial NCT06463743 · RECRUITING

Trial details

NCT number
NCT06463743
Sponsor
State University of New York at Buffalo
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2025-09-24
Primary completion
2027-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.